loadpatents
name:-0.028483867645264
name:-0.012048006057739
name:-0.00050902366638184
Boss; Frank-Gerhard Patent Filings

Boss; Frank-Gerhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boss; Frank-Gerhard.The latest application filed is for "n-biarylamides".

Company Profile
0.13.25
  • Boss; Frank-Gerhard - Berkshire GB
  • Boss; Frank-Gerhard - Wuppertal N/A DE
  • Boss; Frank-Gerhard - Frankfurt DE
  • Boss; Frank-Gerhard - 42115 Wuppertal DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
N-biarylamides
App 20160310474 - Flebner; Timo ;   et al.
2016-10-27
Heteroaryl Carboxamides
App 20160214975 - Hendrix; Martin ;   et al.
2016-07-28
Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes
Grant 9,067,945 - Boss , et al. June 30, 2
2015-06-30
Azabicyclic Carbamates And Their Use As Alpha-7 Nicotinic Acetylcholine Receptor Agonists
App 20150065537 - Flessner; Timo ;   et al.
2015-03-05
N-biarylamides
App 20140288118 - Flebner; Timo ;   et al.
2014-09-25
N-biarylamides
Grant 8,691,840 - Flessner , et al. April 8, 2
2014-04-08
Selective Phosphodiesterase 9a Inhibitors As Medicaments For Improving Cognitive Processes
App 20130245045 - Boss; Frank-Gerhard ;   et al.
2013-09-19
Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes
Grant 8,455,502 - Boss , et al. June 4, 2
2013-06-04
Azabicyclic Carbamates And Their Use As Alpha-7 Nicotinic Acetylcholine Receptor Agonists
App 20130060039 - Flessner; Timo ;   et al.
2013-03-07
2-heteroaryl Carboxamides
App 20120258964 - Luithle; Joachim ;   et al.
2012-10-11
Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
Grant 8,153,799 - Flessner , et al. April 10, 2
2012-04-10
2-heteroaryl Carboxamides
App 20110263591 - Luithle; Joachim ;   et al.
2011-10-27
N-biarylamides
Grant 8,030,329 - Flessner , et al. October 4, 2
2011-10-04
Azabicyclic Carbamates And Their Use As Alpha-7 Nicotinic Acetylcholine Receptor Agonists
App 20100324085 - Flessner; Timo ;   et al.
2010-12-23
Selective Phosphodiesterase 9a Inhibitors As Medicaments For Improving Cognitive Processes
App 20100210839 - Boss; Frank-Gerhard ;   et al.
2010-08-19
N-Biarylamides
App 20080214602 - Flessner; Timo ;   et al.
2008-09-04
Heteroaryl carboxamides
App 20080009624 - Hendrix; Martin ;   et al.
2008-01-10
Heteroaryl carboxylic acid amides
Grant 7,256,288 - Hendrix , et al. August 14, 2
2007-08-14
Bicyclic N-arylamides
Grant 7,247,728 - Luithle , et al. July 24, 2
2007-07-24
N-biarylamides
App 20070112023 - Flessner; Timo ;   et al.
2007-05-17
Aza-bicyclic N-biarylamides with affinity for the .alpha.7 nicotinic acetylcholine receptor
Grant 7,138,410 - Luithle , et al. November 21, 2
2006-11-21
2-Heteroaryl carboxamides
App 20060160877 - Luithle; Joachim ;   et al.
2006-07-20
Alkyl-substituted pyrazolopyrimidines
App 20060111372 - Hendrix; Martin ;   et al.
2006-05-25
Phenyl-substituted pyrazolopyrimidines
App 20060106035 - Hendrix; Martin ;   et al.
2006-05-18
Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
App 20060100222 - Boss; Frank-Gerhard ;   et al.
2006-05-11
Selective PDE 2 inhibitors as pharmaceuticals for improving perception
Grant 7,022,709 - Boss , et al. April 4, 2
2006-04-04
Substituted imidazotriazinones
Grant 6,998,402 - Niewohner, legal representative , et al. Februar
2006-02-14
Heteroaryl carboxylic acid amides
App 20050209236 - Hendrix, Martin ;   et al.
2005-09-22
Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
App 20050154045 - Luithle, Joachim ;   et al.
2005-07-14
2-Heteroarylcarboxylic acid amides
App 20050119325 - Hendrix, Martin ;   et al.
2005-06-02
Bicyclic n-arylamides
App 20050107460 - Luithle, Joachim ;   et al.
2005-05-19
Substituted imidazotriazinones
App 20020198377 - Niewohner, Ulrich ;   et al.
2002-12-26
Selective PDE 2 inhibitors as pharmaceuticals for improving perception
App 20020132754 - Boss, Frank-Gerhard ;   et al.
2002-09-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed